The expression of the protooncogenes ETSI and ETS2 has been studied in purifled human T cells activated either by cross-linking of the T-cell receptor-CD3 complex on their cell surface or by direct stimulation with phorbol esters and ionomycin. Our results show that resting T cells express high levels of ETS1 mRNA and protein, while expression of ETS2 is undetectable. Upon T-cell activation, ETS2 mRNA and proteins are induced, while ETSI gene expression decreases to very low levels. Late after stimulation, ETS1 mRNA is reinduced and maintained at a high level, while ETS2 gene expression decreases to undetectable levels. Therefore, it appears that in human T cells, ETS2 gene products are associated with cellular activation and proliferation, while ETSI gene products are preferentially expressed in a quliescent state.
The cellular c-ets family ofgenes have been identified by their sequence similarities with the viral v-ets oncogene of the E26 avian leukemia virus (1, 2) . The c-ets-1 (3-5), c-ets-2 (3, 4), c-erg (6, 7), c-elk-i, and c-elk-2 genes (8) are members of the c-ets family ofgenes. In humans, ETSI and ETS2 are localized on different chromosomes (9) and code for distinct sets of mRNA (3, 5) and proteins (10) (11) (12) . ETSJ and ETS2 code for structurally related proteins (70%o similarity) (4) that are primarily localized in the nucleus (10, 13) and are capable of binding to DNA (13) . The DNA-binding domain has been localized to the carboxyl terminus ofETS1 (14) , a region highly conserved among all ETS family members (4) . Both ETS1 and ETS2 proteins are labile nuclear phosphoproteins (10, 12, 15) . They share many properties with other nuclear oncogene products like JUN, FOS, and MYC: nuclear localization, rapid turnover, and quick response to second messengers, suggesting that the c-ets gene products may also play a vital role during cell growth. In fact, the gene transfection and subsequent overexpression ofmurine Ets-2 has recently been shown to abolish the serum requirement for cell growth and stimulate the proliferation of NIH 3T3 fibroblasts (16) .
Although c-ets-1 mRNA is detectable in different murine (17) (18) (19) and human tissues (20, 21) , c-ets-1 mRNA and proteins are expressed at high levels in the thymus. Thymus is the major site for T-cell development, differentiation, and functional maturation. Initially, the thymus is populated by CD4-CD8-(DN, double negative) cells, some of which will differentiate into CD4+ CD8+ (DP, double positive) cells.
The single-positive CD4+ CD8-or CD4-CD8+ thymocytes emerge later and subsequently migrate from the thymus into peripheral lymphoid sites (22) . We have shown that: (i) the murine Ets-2 expression appears 1 day earlier than Ets-J expression, corresponding to both DN and DP blast thymocytes; (ii) the Ets-1 expression begins in 18-day-old fetal thymocytes, coinciding with the appearance of singlepositive thymocytes; (iii) both Ets-J and Ets-2 genes are selectively expressed in CD4+ CD8-thymocytes rather than in DN or CD8+ CD4-subsets; (iv) both Ets-l and Ets-2 expression are detectable in peripheral T cells (19) .
T cells are very important components and regulators of the immune response. T cells are activated to proliferate by interaction between T-cell receptor (TCR) and antigen in conjunction with a major histocompatibility complex protein recognized on antigen-presenting cells (23) . This interaction initiates a cascade of intracellular biochemical events leading to elevation of intracellular Ca2+ ions and activation of protein kinase C (PKC) (23) . T cells can also be activated in vitro after direct activation of PKC by phorbol esters and increase of intracellular Ca2+ ions by ionomycin (24) .
To understand the role of c-ets gene products in T cells, we have studied the expression and regulation ofETS1 and ETS2 genes during human T-cell activation and proliferation. In this paper, we report that the resting human T lymphocytes express high levels of ETS1 and very low levels of ETS2 mRNA and proteins. Upon T-cell activation, ETS2 gene products are induced while the ETS1 mRNA and proteins are decreased. While ETS2 gene products appear to be required for cellular activation and proliferation, the ETS1 gene products may be involved in maintaining T cells in a quiescent state. Taken together, our results suggest that ETS1 and ETS2 genes may have a reciprocal relationship in the regulation of human T-cell activation.
MATERIALS AND METHODS Cells. Resting human peripheral T cells were isolated from buffy coats obtained by leukophoresis of healthy donors as described (25) . These cells were coated with saturating amounts of murine inonoclonal antibodies (mAbs) 60.1 (anti-CD11), IF5 (anti-CD20), FC2 (anti-CD16), and 63D3 (anti-CD14). 3 ng/ml) or phorbol 12,13-dibutyrate (3 ng/ml) or ionomycin (800 ng/ml) or a combination of PMA and ionomycin. An optimal amount of anti-CD3 antibody attached to a plastic surface was used to cross-link the TCR-CD3 complex as described (26) . Cells were harvested, and RNA was isolated by the guanidinium isothiocyanate/cesium chloride method Abbreviations: TCR, T-cell receptor; PMA, phorbol 12-myristate 13-acetate; PKC, protein kinase C; mAb, monoclonal antibody.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (27) . Total RNA in each sample was normalized with respect to 28S ribosomal RNA as described (26) . Equal amounts of RNA were size-fractionated on a denaturing formaldehyde gel and blotted onto membrane. Probe preparation, hybridization, washing, and autoradiography were carried out as described (26) . The size of ETS1 and ETS2 transcripts was measured by comparing the mobility of 28S and 18S rRNA and other RNA of known size detected on the blot. Consistently, a 6.8-kilobase (kb) major ETS1 RNA and three ETS2 mRNAs (4.7, 3.2, and 2.7 kb) were detected as reported (3). The 2.7-kb ETS2 mRNA could be detected easily from poly(A)+ RNA blots as a faint band just below the 3.2-kb mRNA from total RNA blots.
DNA Probes. Human ETS1 (PRD700)-and ETS2 (CDNA14)-specific DNA fragments (3) were labeled with 32P by nicktranslation and used as probes. A 3' end of a human ETSJspecific cDNA probe or an ETS2-specific probe H33 were also used in some experiments, which gave an identical pattern to those two probes described above (data not shown).
Immunoprecipitation (refs. 15, 28 , and 29; S.K., unpublished data). The proteins were size-fractionated on denaturing polyacrylamide gel and processed for fluorography by using Enlightening (NEN) as described before (10) . RESULTS ETSI Gene Is Expressed at a High Level in Resting Human T Cells. We have shown in murine cells (19) that the levels of both Ets-1 and Ets-2 mRNA are lower in peripheral T cells than in thymocytes. The lower expression could be due to differences in either the microenvironment or the growth status of these cells. To test if c-ets genes are expressed at higher levels in quiescent vs. activated cells, we studied c-ets gene expression during T-cell activation and proliferation. Previously it has been shown that human peripheral T cells, when prepared as described in methods, are >98% pure and are in a quiescent state (25, 26, 30) . The purified T cells used in this study are depleted of accessory cells and do not proliferate in vitro after stimulation with phytohemagglutinin, PMA, or ionomycin alone (26, 30) . However, these T cells can be stimulated to divide by cross-linking the TCR-CD3 complex with a mAb attached to a plastic surface or by using the optimal amount of PMA and ionomycin as described (26) . Under these conditions, >90% of the resting T cells are activated and the majority of the cells synchronously proceed through one round of cell proliferation. Total (Fig. 2) . When added together, these two agents acted synergistically, causing an even more profound decrease in ETSJ expression (Fig. 2) .
To Figs. 1 and 2 ). The level of HLA class I mRNA remained relatively unchanged during the drug treatment as reported (26) . These results strongly suggest that both PKC activation and increase of Ca2+ ions play functional roles in ETS2 induction and ETS1 repression.
ETS1 and ETS2 Protein Levels in Resting Versus Activated T Cells. To determine whether the differences observed in the ETS mRNA levels are reflected at the protein level, the ETS1 and ETS2 proteins were examined by using well-characterized human ETS1-and ETS2-specific mAbs (refs. 28 and 29; S.K., unpublished data). In resting human T cells, all ETS1 proteins (p5i, p48, p42, and p39 of 51, 48, 42, and 39 kDa, respectively) were expressed (Fig. 3) . The lower levels of p42 and p39 detected in these cells could be the result of a high ratio of unspliced-to-alternatively-spliced ETS1 mRNA in quiescent T cells (C. Jorcyk, personal communication). These ETS1 proteins were undetected in activated cells (Fig.  3, compare lanes 2 and 4) . In contrast, the ETS2 proteins are expressed at a high level in activated T cells and at undetectable levels in resting T cells (Fig. 3, compare lanes 1 and  3) . Thus, we can conclude that during T-cell 4 Middle, lanes 1 and 2). However, during T-cell activation, new protein synthesis appeared to be required for ETS2 mRNA induction and to effect a decrease in ETS1 mRNA levels (Fig. 4 Middle, lanes 3 and 4) . Proc. Natl. Acad. Sci. USA 87 (1990) gens, and lymphokines) to cell surface receptors. Such interaction generates a cascade of intracellular biochemical events leading to activation of PKC, elevation of intracellular Ca2l ions, and other second messengers (23) . Generation of such signals results in the activation of resting cells, allowing them to emerge from Go, and progress into the G1 phase ofthe cell cycle. During cell proliferation, genes expressed in the G1 phase of the cell cycle are positively regulated, while those genes expressed in the Go phase may be negatively regulated (31) . Thus, the commitment of cells to proliferate depends upon how these two sets ofgenetic programs are regulated by second messengers that are stimulated by ligand-receptor interactions occurring at the cell surface level. During T-cell proliferation, both T cell-specific gene products such as lymphokines and a number of other gene products common to different cell types, including protooncogene products, have been shown to be expressed transiently (refs. 26, 30 , and 32-35; for a review, see ref. 32). All of these genes can be grouped and categorized into immediate-, early-, and lateresponse genes, depending on their pattern of expression before or after cell division and their requirement for new protein synthesis during their induction (32) . Both immediate-and early-response genes are induced prior to cell division. Expression of immediate-response genes is independent of new protein synthesis; for the induction of earlyresponse genes, active protein synthesis is necessary. Lateresponse genes are expressed after cell division and also require active protein synthesis.
Results presented in this paper show that ETS2 mRNA and proteins are induced during the early phase of T-cell proliferation, thus enabling us to place c-ets-2 genes along with other "early response genes" such as those encoding ornithine decarboxylase, cyclin, myb, and lymphokine gene products (32 (38) , and six growth-arrest-specific genes (39)-also have been shown to be expressed at higher levels in quiescent cells but not in proliferating cells. In contrast to other genes, the protooncogene ETSJ encodes a labile nuclear phosphoprotein with DNA-binding properties (10, 13, 14) , which suggests that this protein may be a regulator rather than a marker of the quiescent state in human T cells. Sequence analyses of mammalian c-ets-1 and c-ets-2 genes indicate that the carboxyl-terminal domain is highly conserved among many members of this family of genes (4) . This domain contains the consensus nuclear localization signal starting at position 376: Gly-Lys-Arg-Lys-Asn-Lys-Pro-Lys (numbering as in ref. 4 (15) . The hyperphosphorylated murine Ets-1 has lower affinity for DNA than the nonphosphorylated form (13) .
Data presented in this paper along with other known properties of ETS1 and ETS2 proteins (10-15, 29, 42) are consistent with the model shown in Fig. 5 Thus, signals generated during T-cell activation have pleiotropic and reciprocal effects on ETSI and ETS2 gene expression, the immediate effect being at the posttranslation level and a later effect being at the transcriptional or posttranscriptional level.
We have shown previously that the murine Ets-2 mRNA is induced during the early phase of hepatic (17) and fibroblast cell growth (18) and that this induction is independent of new protein synthesis (17, 18) . However, in human T cells, ETS2 induction requires new protein synthesis (Fig. 4) . The ETS2 expression follows a pattern similar (with respect to its induction and requirements for new protein synthesis) to that observed for MYB, another oncogene transduced by E26 virus (34) . Since MYB gene products are shown to be required for the G1-S transition (43), we can speculate that the ETS2 gene products may similarly cooperate in this cell cycle transition. One can also speculate that the ETSJ gene products, by themselves or in cooperation with other gene products, maintain T cells in a quiescent state by repressing immediate-or early-response genes or by inducing genes that are expressed at higher levels in resting state. Change in ETSI and ETS2 expressions that we have observed during T-cell activation/proliferation could be due also to the results of other events that are more intimately linked with the proliferative state of the cell.
